Peptides & Longevity
Building a Nationwide B2B Peptides Pipeline for Clinics and Wellness Providers
A peptides brand with strong direct-to-consumer traction needed a scalable B2B commercialization system. We rebuilt the strategy around healthcare provider expectations and opened a nationwide clinic pipeline.
2X
Revenue Growth
Nationwide
Clinic Pipeline
6 Months
Growth Timeline
Context
Company: Atomix Research
Segment: Peptides & Longevity
Timeframe: 6 months
Challenge
The company had strong direct-to-consumer traction and operational readiness - including COAs, fulfillment infrastructure, and high-purity products - but lacked a scalable B2B commercialization system for clinics and provider groups.
Diagnosis
There was no structured clinic acquisition system, no provider onboarding workflow, and weak positioning for healthcare buyers. Pricing was not optimized for clinics, there were no strategic compounding partnerships, and no provider-focused ordering infrastructure.
Commercial Impact
Healthcare providers respond to operational reliability, fulfillment confidence, and patient continuity more than product-only messaging. The positioning shifted from peptide sales to clinic workflow support and long-term provider relationships.
Strategy
- Rebuilt the commercialization strategy around healthcare provider expectations rather than consumer positioning.
- Repositioned the B2B portal and optimized provider pricing for clinic buyers.
- Established strategic 503A compounding pharmacy partnerships.
Execution
- Ran HRT clinic targeting, functional medicine outreach, and med spa acquisition.
- Onboarded wellness clinics through multichannel provider outreach.
- Refined turnaround time to strengthen clinic ordering confidence.
Client perspective
“Medix understood the healthcare side of peptide commercialization immediately. Their team knew how clinics evaluate suppliers, how providers think, and how to build a real B2B pipeline instead of generic outreach.”
Lincoln McDonald, Founder at Atomix Research
Key learnings
- Healthcare providers respond to operational reliability and patient continuity more than product-only messaging.
- B2B peptide growth accelerates when positioning shifts from product sales to clinic workflow support.
Next step